Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Cash from Financing Activities (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Cash from Financing Activities for 3 consecutive years, with $11.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 91.45% year-over-year to $11.3 million, compared with a TTM value of $25.9 million through Sep 2025, up 45.32%, and an annual FY2024 reading of $17.6 million, up 69.48% over the prior year.
  • Cash from Financing Activities was $11.3 million for Q3 2025 at SeaStar Medical Holding, up from $4.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $11.3 million in Q3 2025 and bottomed at -$1.0 million in Q2 2024.
  • Average Cash from Financing Activities over 3 years is $4.5 million, with a median of $4.4 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities crashed 169.73% in 2024, then surged 494.98% in 2025.
  • Year by year, Cash from Financing Activities stood at $4.6 million in 2023, then fell by 3.44% to $4.4 million in 2024, then surged by 155.19% to $11.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for ICU at $11.3 million in Q3 2025, $4.0 million in Q2 2025, and $6.1 million in Q1 2025.